Silgan (SLGN) Financials

$48.93 -0.61 (-1.23%)

As of 03:04 PM Eastern

Annual Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	172	153	270	224	194	309	359	341	326	276
Consolidated Net Income / (Loss)	172	153	270	224	194	309	359	341	326	276
Net Income / (Loss) Continuing Operations	172	153	270	224	194	309	359	341	326	276
Total Pre-Tax Income	253	232	240	293	252	407	466	474	422	348
Total Operating Income	320	300	357	412	359	512	576	602	595	515
Total Gross Profit	554	512	635	690	714	867	918	1,048	993	1,012
Total Revenue	3,764	3,613	4,090	4,449	4,490	4,922	5,677	6,411	5,988	5,855
Operating Revenue	3,764	3,613	4,090	4,449	4,490	4,922	5,677	6,411	5,988	5,855
Total Cost of Revenue	3,210	3,101	3,455	3,759	3,776	4,055	4,759	5,364	4,996	4,843
Operating Cost of Revenue	3,210	3,101	3,455	3,759	3,776	4,055	4,759	5,364	4,996	4,843
Total Operating Expenses	234	212	278	278	354	355	342	446	397	497
Selling, General & Admin Expense	220	220	305	308	316	378	378	417	384	438
Restructuring Charge	14	19	5.83	6.25	56	16	15	74	8.41	59
Other Special Charges / (Income)	-	-27	-33	-37	-18	-39	-51	-45	4.33	-1.19
Total Other Income / (Expense), net	-67	-68	-117	-119	-107	-105	-110	-128	-173	-167
Interest Expense	67	68	117	119	107	105	110	128	173	167
Income Tax Expense	80	79	-30	69	58	98	107	133	96	72
Other Gains / (Losses), net	-	-	-	-	-	-	-	0.00	0.00	0.69
Basic Earnings per Share	$1.41	$1.28	$2.44	$2.03	$1.75	$2.79	$3.25	$3.09	$3.00	$2.59
Weighted Average Basic Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Diluted Earnings per Share	$1.41	$1.27	$2.42	$2.01	$1.74	$2.77	$3.23	$3.07	$2.98	$2.58
Weighted Average Diluted Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Weighted Average Basic & Diluted Shares Outstanding	61.02M	119.73M	110.35M	110.60M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Cash Dividends to Common per Share	$0.32	$0.68	$0.36	$0.40	$0.44	$0.48	$0.56	$0.64	$0.72	$0.76

This table shows Silgan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	139	25	72	79	111	64	55	76	100	45
Consolidated Net Income / (Loss)	139	25	72	79	111	64	55	76	100	45
Net Income / (Loss) Continuing Operations	139	25	72	79	111	64	55	76	100	45
Total Pre-Tax Income	186	47	94	97	147	84	73	101	125	49
Total Operating Income	219	81	131	144	194	126	112	142	167	94
Total Gross Profit	308	233	238	250	286	219	223	256	293	239
Total Revenue	1,970	1,455	1,418	1,427	1,803	1,340	1,317	1,381	1,745	1,411
Operating Revenue	1,970	1,455	1,418	1,427	1,803	1,340	1,317	1,381	1,745	1,411
Total Cost of Revenue	1,663	1,223	1,180	1,177	1,517	1,122	1,094	1,125	1,452	1,172
Operating Cost of Revenue	1,663	1,223	1,180	1,177	1,517	1,122	1,094	1,125	1,452	1,172
Total Operating Expenses	88	152	107	106	92	92	112	114	126	145
Selling, General & Admin Expense	97	96	101	102	84	97	100	108	106	124
Restructuring Charge	2.73	67	4.12	2.67	6.42	-4.80	12	6.86	19	21
Other Special Charges / (Income)	-11	-12	1.29	1.30	1.08	0.67	-0.41	-0.41	0.12	-0.49
Total Other Income / (Expense), net	-34	-35	-37	-47	-47	-42	-39	-41	-42	-46
Interest Expense	34	35	37	47	47	42	39	41	42	46
Income Tax Expense	47	22	22	18	36	19	18	24	25	4.29
Basic Earnings per Share	$1.26	$0.22	$0.65	$0.72	$1.02	$0.61	$0.52	$0.71	$0.94	$0.42
Weighted Average Basic Shares Outstanding	110.28M	110.08M	110.22M	110.13M	108.42M	106.50M	106.65M	106.84M	106.85M	106.79M
Diluted Earnings per Share	$1.25	$0.23	$0.65	$0.71	$1.02	$0.60	$0.52	$0.71	$0.93	$0.42
Weighted Average Diluted Shares Outstanding	110.74M	110.08M	110.85M	110.45M	108.75M	106.50M	107.05M	107.02M	107.14M	106.79M
Weighted Average Basic & Diluted Shares Outstanding	110.08M	110.08M	110.25M	109.95M	106.50M	106.50M	106.78M	106.78M	106.79M	106.79M

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-123	-75	29	19	131	206	222	-46	57	180
Net Cash From Operating Activities	336	395	390	507	507	603	557	748	483	722
Net Cash From Continuing Operating Activities	336	395	390	507	507	603	557	748	483	722
Net Income / (Loss) Continuing Operations	172	153	270	224	194	309	359	341	326	276
Consolidated Net Income / (Loss)	172	153	270	224	194	309	359	341	326	276
Depreciation Expense	142	143	174	192	206	219	250	263	263	276
Amortization Expense	4.16	4.14	4.26	3.77	3.46	4.54	5.57	5.46	5.37	5.47
Non-Cash Adjustments To Reconcile Net Income	26	32	28	24	75	36	97	92	24	76
Changes in Operating Assets and Liabilities, net	-9.48	62	-86	63	28	34	-155	47	-136	88
Net Cash From Investing Activities	-237	-180	-1,198	-190	-230	-1,163	-976	-216	-224	-1,176
Net Cash From Continuing Investing Activities	-237	-180	-1,198	-190	-230	-1,163	-976	-216	-224	-1,176
Purchase of Property, Plant & Equipment	-237	-192	-174	-191	-231	-224	-232	-216	-227	-263
Acquisitions	-0.69	0.00	-1,024	0.00	0.00	-941	-746	-2.50	0.00	-922
Sale of Property, Plant & Equipment	0.90	-	-	-	-	-	2.80	3.35	1.76	7.80
Other Investing Activities, net	-	12	0.60	1.05	0.85	1.87	-0.82	-0.69	1.24	0.26
Net Cash From Financing Activities	-221	-289	837	-294	-146	760	649	-570	-211	663
Net Cash From Continuing Financing Activities	-221	-289	837	-294	-146	760	649	-570	-211	663
Repayment of Debt	-767	-865	-2,089	-1,280	-462	-1,831	-2,106	-1,120	-1,179	-1,120
Repurchase of Common Equity	-173	-281	-4.12	-7.83	-28	-42	-8.57	-45	-184	-9.32
Payment of Dividends	-40	-41	-40	-45	-51	-54	-62	-72	-79	-82
Issuance of Debt	740	919	2,961	1,043	400	2,681	2,685	835	1,134	1,977
Other Financing Activities, net	19	-23	8.85	-4.13	-4.66	5.20	140	-167	96	-103
Effect of Exchange Rate Changes	-	0.00	0.00	-3.70	-0.74	6.47	-7.53	-9.03	9.91	-28
Cash Interest Paid	64	65	98	118	109	90	102	124	155	160
Cash Income Taxes Paid	50	58	70	47	41	121	94	94	116	92

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-4.23	342	-85	-264	71	336	-334	-5.85	66	454
Net Cash From Operating Activities	234	866	-632	-180	216	1,079	-548	21	313	936
Net Cash From Continuing Operating Activities	234	866	-632	-180	216	1,079	-548	21	313	936
Net Income / (Loss) Continuing Operations	139	25	72	79	111	64	55	76	100	45
Consolidated Net Income / (Loss)	139	25	72	79	111	64	55	76	100	45
Depreciation Expense	65	61	65	67	65	67	66	66	67	77
Amortization Expense	-	-	1.33	1.34	1.35	1.34	1.35	1.35	1.35	1.43
Non-Cash Adjustments To Reconcile Net Income	6.77	70	7.80	6.14	11	-0.58	16	11	23	26
Changes in Operating Assets and Liabilities, net	24	705	-778	-333	28	947	-687	-133	122	786
Net Cash From Investing Activities	-41	-54	-67	-50	-54	-53	-72	-56	-61	-987
Net Cash From Continuing Investing Activities	-41	-54	-67	-50	-54	-53	-72	-56	-61	-987
Purchase of Property, Plant & Equipment	-44	-53	-68	-50	-55	-53	-75	-56	-61	-71
Sale of Property, Plant & Equipment	-	-	0.37	0.30	0.95	0.13	2.50	0.49	0.24	4.58
Other Investing Activities, net	2.68	-2.68	0.51	0.06	0.70	-0.03	0.30	-0.25	-0.34	0.55
Net Cash From Financing Activities	-187	-479	610	-36	-86	-699	293	36	-195	528
Net Cash From Continuing Financing Activities	-187	-479	610	-36	-86	-699	293	36	-195	528
Repayment of Debt	-236	-529	-79	-216	-39	-845	-115	-60	-235	-709
Repurchase of Common Equity	-	-5.72	-13	-18	-153	-0.05	-7.68	-0.06	-	-1.58
Payment of Dividends	-18	-18	-21	-20	-19	-19	-21	-20	-20	-20
Issuance of Debt	66	15	786	218	125	5.79	598	142	63	1,174
Other Financing Activities, net	-	59	-62	-0.86	-0.69	160	-161	-25	-2.01	85
Effect of Exchange Rate Changes	-9.96	9.11	3.83	1.86	-5.18	9.41	-6.69	-	-	-23
Cash Interest Paid	32	33	35	46	43	31	50	41	43	27
Cash Income Taxes Paid	38	27	20	65	11	20	17	27	26	22

This table presents Silgan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	3,193	3,149	4,645	4,579	4,931	6,512	7,771	7,346	7,611	8,585
Total Current Assets	1,045	962	1,292	1,290	1,407	1,799	2,296	2,133	2,349	2,523
Cash & Equivalents	100	25	54	73	204	409	631	586	643	823
Accounts Receivable	281	288	455	511	505	620	711	658	600	594
Inventories, net	628	603	721	635	633	678	799	769	941	928
Prepaid Expenses	36	46	62	71	65	93	154	120	166	177
Plant, Property, & Equipment, net	1,125	1,157	1,490	1,518	0.00	0.00	1,994	1,931	1,962	2,283
Total Noncurrent Assets	1,022	1,030	1,864	1,772	3,524	4,712	3,481	3,282	3,301	3,779
Goodwill	613	605	1,171	1,148	1,142	1,741	2,038	1,985	2,018	2,316
Intangible Assets	195	181	417	383	355	637	831	764	721	869
Other Noncurrent Operating Assets	214	245	275	240	2,027	2,334	612	533	561	594
Total Liabilities & Shareholders' Equity	3,193	3,149	4,645	4,579	4,931	6,512	7,771	7,346	7,611	8,585
Total Liabilities	2,553	2,680	3,879	3,698	3,908	5,259	6,208	5,628	5,722	6,595
Total Current Liabilities	781	862	958	1,079	1,019	1,192	1,509	1,438	2,312	2,248
Short-Term Debt	152	217	109	170	30	28	20	80	880	717
Accounts Payable	477	505	660	713	727	803	1,133	974	1,076	1,112
Accrued Expenses	107	94	124	127	195	231	246	285	258	310
Current Employee Benefit Liabilities	45	46	66	69	67	130	109	99	98	109
Total Noncurrent Liabilities	1,772	1,818	2,921	2,619	2,889	4,067	4,700	4,190	3,410	4,348
Long-Term Debt	1,361	1,344	2,439	2,134	2,215	3,223	3,773	3,345	2,546	3,420
Noncurrent Deferred & Payable Income Tax Liabilities	-	298	262	268	255	356	435	389	434	506
Other Noncurrent Operating Liabilities	411	175	220	217	420	488	491	456	430	422
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990
Total Preferred & Common Equity	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990
Total Common Equity	639	469	766	881	1,023	1,253	1,563	1,718	1,889	1,990
Common Stock	238	251	264	278	291	308	327	342	356	370
Retained Earnings	1,446	1,559	1,810	1,998	2,141	2,395	2,692	2,961	3,208	3,403
Treasury Stock	-836	-1,116	-1,119	-1,126	-1,149	-1,190	-1,196	-1,239	-	-1,429
Accumulated Other Comprehensive Income / (Loss)	-209	-224	-189	-269	-260	-261	-260	-345	-251	-353

This table presents Silgan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	7,519	7,862	7,914	7,812	7,574	7,693	7,747
Total Current Assets	2,332	2,625	2,698	2,662	2,376	2,539	2,519
Cash & Equivalents	244	501	237	307	309	303	369
Accounts Receivable	1,124	936	1,068	1,296	946	1,057	1,210
Inventories, net	851	1,055	1,252	919	957	1,006	780
Prepaid Expenses	113	133	143	140	164	173	160
Plant, Property, & Equipment, net	1,887	1,930	1,934	1,912	1,944	1,934	1,956
Total Noncurrent Assets	3,301	3,307	3,281	3,239	3,254	3,221	3,272
Goodwill	1,915	2,002	2,007	1,980	1,997	1,987	2,024
Intangible Assets	758	756	745	724	702	685	681
Other Noncurrent Operating Assets	628	549	528	535	555	549	566
Total Liabilities & Shareholders' Equity	7,519	7,862	7,914	7,812	7,574	7,693	7,747
Total Liabilities	5,826	6,080	6,043	6,030	5,674	5,760	5,693
Total Current Liabilities	1,681	1,844	1,880	1,916	2,289	2,396	2,306
Short-Term Debt	591	785	811	898	1,346	1,398	1,254
Accounts Payable	688	716	752	652	610	658	679
Accrued Expenses	291	241	222	269	234	239	266
Current Employee Benefit Liabilities	110	102	95	96	100	101	106
Total Noncurrent Liabilities	4,145	4,236	4,163	4,115	3,385	3,364	3,388
Long-Term Debt	3,247	3,370	3,351	3,313	2,535	2,531	2,554
Noncurrent Deferred & Payable Income Tax Liabilities	425	389	384	380	432	425	421
Other Noncurrent Operating Liabilities	473	477	427	422	418	408	413
Total Equity & Noncontrolling Interests	1,693	1,781	1,871	1,782	1,900	1,934	2,054
Total Preferred & Common Equity	1,693	1,781	1,871	1,782	1,900	1,934	2,054
Total Common Equity	1,693	1,781	1,871	1,782	1,900	1,934	2,054
Common Stock	338	344	347	351	358	362	366
Retained Earnings	2,954	3,013	3,072	3,163	3,243	3,299	3,378
Accumulated Other Comprehensive Income / (Loss)	-365	-325	-280	-310	-272	-298	-261
Other Equity Adjustments	-1,233	-1,251	-1,269	-1,423	-1,429	-1,429	-1,429

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.78%	-4.01%	13.20%	8.78%	0.92%	9.62%	15.34%	12.94%	-6.60%	-2.23%
EBITDA Growth	-9.16%	-4.13%	19.78%	13.51%	-6.28%	29.26%	13.04%	4.59%	-0.71%	-7.82%
EBIT Growth	-11.37%	-6.28%	19.10%	15.44%	-12.77%	42.53%	12.44%	4.49%	-1.08%	-13.49%
NOPAT Growth	-5.73%	-9.10%	102.65%	-21.64%	-12.20%	40.62%	14.17%	-2.46%	6.25%	-11.17%
Net Income Growth	-5.47%	-11.06%	75.84%	-16.93%	-13.47%	59.29%	16.31%	-5.08%	-4.37%	-15.21%
EPS Growth	-50.70%	-9.93%	90.55%	-16.94%	-13.43%	59.20%	16.61%	-4.95%	-2.93%	-13.42%
Operating Cash Flow Growth	-3.58%	17.51%	-1.21%	29.96%	0.16%	18.75%	-7.58%	34.40%	-35.52%	49.58%
Free Cash Flow Firm Growth	-43.25%	3.37%	-448.17%	154.17%	-29.47%	-297.29%	71.01%	421.82%	-42.47%	-164.39%
Invested Capital Growth	-0.90%	-2.26%	62.48%	-4.50%	-1.58%	33.64%	15.38%	-3.52%	2.53%	13.49%
Revenue Q/Q Growth	-2.10%	-0.65%	4.87%	1.71%	-0.49%	3.76%	3.89%	0.25%	-1.89%	1.23%
EBITDA Q/Q Growth	-0.83%	0.95%	10.31%	-0.68%	0.31%	6.36%	4.79%	-4.98%	6.93%	-2.58%
EBIT Q/Q Growth	-2.02%	-0.10%	10.60%	-2.16%	-1.61%	7.00%	4.29%	-7.32%	8.17%	-5.83%
NOPAT Q/Q Growth	1.73%	-1.55%	84.55%	-32.45%	-2.67%	7.90%	6.92%	-12.46%	12.41%	-3.39%
Net Income Q/Q Growth	1.72%	-1.83%	83.15%	-32.52%	-1.70%	8.91%	7.46%	-15.06%	13.92%	-6.55%
EPS Q/Q Growth	-48.91%	323.33%	120.00%	-32.55%	-1.69%	9.06%	7.31%	-14.72%	14.18%	-6.52%
Operating Cash Flow Q/Q Growth	-4.96%	6.15%	-2.96%	24.36%	3.33%	-4.09%	16.43%	68.15%	78.81%	-16.52%
Free Cash Flow Firm Q/Q Growth	-36.06%	42.77%	-1.91%	37.43%	-26.30%	-5.23%	56.11%	15.50%	2,913.15%	-136.11%
Invested Capital Q/Q Growth	-16.10%	-18.99%	-7.66%	-14.95%	-12.52%	-8.46%	-11.06%	-13.80%	-17.80%	-3.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.72%	14.17%	15.52%	15.50%	15.90%	17.62%	16.18%	16.34%	16.58%	17.28%
EBITDA Margin	12.38%	12.37%	13.09%	13.66%	12.68%	14.95%	14.66%	13.57%	14.43%	13.60%
Operating Margin	8.50%	8.30%	8.73%	9.26%	8.01%	10.41%	10.15%	9.39%	9.94%	8.80%
EBIT Margin	8.50%	8.30%	8.73%	9.26%	8.01%	10.41%	10.15%	9.39%	9.94%	8.80%
Profit (Net Income) Margin	4.58%	4.24%	6.59%	5.03%	4.32%	6.27%	6.33%	5.32%	5.44%	4.72%
Tax Burden Percent	68.18%	66.12%	112.51%	76.37%	76.87%	75.84%	77.00%	71.89%	77.22%	79.49%
Interest Burden Percent	79.07%	77.38%	67.14%	71.17%	70.14%	79.45%	80.94%	78.77%	70.89%	67.50%
Effective Tax Rate	31.82%	33.88%	-12.51%	23.63%	23.13%	24.16%	23.00%	28.11%	22.78%	20.70%
Return on Invested Capital (ROIC)	10.57%	9.77%	15.25%	9.88%	8.95%	10.86%	10.06%	9.32%	9.96%	8.19%
ROIC Less NNEP Spread (ROIC-NNEP)	7.29%	6.73%	8.70%	6.04%	5.08%	7.59%	7.24%	6.26%	5.20%	3.86%
Return on Net Nonoperating Assets (RNNOA)	14.99%	17.90%	28.40%	17.32%	11.41%	16.27%	15.45%	11.45%	8.11%	6.06%
Return on Equity (ROE)	25.56%	27.67%	43.65%	27.19%	20.35%	27.13%	25.51%	20.78%	18.07%	14.25%
Cash Return on Invested Capital (CROIC)	11.48%	12.06%	-32.35%	14.48%	10.54%	-17.94%	-4.22%	12.91%	7.47%	-4.45%
Operating Return on Assets (OROA)	9.89%	9.45%	9.16%	8.93%	7.56%	8.96%	8.07%	7.96%	7.96%	6.36%
Return on Assets (ROA)	5.33%	4.84%	6.92%	4.86%	4.08%	5.40%	5.03%	4.51%	4.36%	3.41%
Return on Common Equity (ROCE)	25.56%	27.67%	43.65%	27.19%	20.35%	27.13%	25.51%	20.78%	18.07%	14.25%
Return on Equity Simple (ROE_SIMPLE)	26.97%	32.67%	35.20%	25.42%	18.94%	24.64%	22.98%	19.84%	17.25%	13.89%
Net Operating Profit after Tax (NOPAT)	218	198	402	315	276	389	444	433	460	408
NOPAT Margin	5.79%	5.49%	9.82%	7.07%	6.15%	7.90%	7.81%	6.75%	7.68%	6.98%
Net Nonoperating Expense Percent (NNEP)	3.29%	3.04%	6.55%	3.84%	3.86%	3.27%	2.82%	3.06%	4.76%	4.33%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.41%	8.65%	6.67%
Cost of Revenue to Revenue	85.28%	85.83%	84.48%	84.50%	84.10%	82.38%	83.82%	83.66%	83.42%	82.72%
SG&A Expenses to Revenue	5.84%	6.09%	7.46%	6.93%	7.03%	7.67%	6.66%	6.50%	6.42%	7.49%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.23%	5.87%	6.79%	6.24%	7.89%	7.21%	6.03%	6.95%	6.63%	8.48%
Earnings before Interest and Taxes (EBIT)	320	300	357	412	359	512	576	602	595	515
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	466	447	535	608	569	736	832	870	864	796
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.25	2.96	3.85	2.74	3.15	3.11	2.91	3.22	2.51	2.79
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.38	0.38	0.72	0.54	0.72	0.79	0.80	0.86	0.79	0.95
Price to Earnings (P/E)	8.35	9.06	10.94	10.76	16.64	12.62	12.68	16.23	14.56	20.11
Dividend Yield	2.68%	2.95%	1.68%	1.84%	1.51%	1.36%	1.36%	1.27%	1.62%	1.46%
Earnings Yield	11.98%	11.04%	9.14%	9.29%	6.01%	7.92%	7.88%	6.16%	6.87%	4.97%
Enterprise Value to Invested Capital (EV/IC)	1.39	1.46	1.67	1.49	1.72	1.65	1.63	1.84	1.61	1.67
Enterprise Value to Revenue (EV/Rev)	0.76	0.81	1.33	1.04	1.17	1.37	1.36	1.31	1.26	1.52
Enterprise Value to EBITDA (EV/EBITDA)	6.12	6.55	10.17	7.64	9.25	9.16	9.27	9.62	8.71	11.14
Enterprise Value to EBIT (EV/EBIT)	8.92	9.76	15.25	11.27	14.65	13.15	13.39	13.91	12.65	17.23
Enterprise Value to NOPAT (EV/NOPAT)	13.09	14.76	13.55	14.75	19.05	17.34	17.39	19.35	16.38	21.72
Enterprise Value to Operating Cash Flow (EV/OCF)	8.50	7.42	13.97	9.17	10.38	11.18	13.86	11.19	15.60	12.29
Enterprise Value to Free Cash Flow (EV/FCFF)	12.06	11.96	0.00	10.06	16.18	0.00	0.00	13.97	21.85	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.37	3.33	3.33	2.62	2.19	2.60	2.43	1.99	1.81	2.08
Long-Term Debt to Equity	2.13	2.86	3.18	2.42	2.16	2.57	2.41	1.95	1.35	1.72
Financial Leverage	2.06	2.66	3.26	2.87	2.24	2.15	2.13	1.83	1.56	1.57
Leverage Ratio	4.79	5.72	6.31	5.60	4.99	5.03	5.07	4.61	4.15	4.18
Compound Leverage Factor	3.79	4.43	4.24	3.99	3.50	3.99	4.11	3.63	2.94	2.82
Debt to Total Capital	70.31%	76.89%	76.88%	72.34%	68.68%	72.18%	70.82%	66.59%	64.46%	67.52%
Short-Term Debt to Total Capital	7.08%	10.69%	3.28%	5.34%	0.91%	0.62%	0.38%	1.56%	16.56%	11.70%
Long-Term Debt to Total Capital	63.23%	66.20%	73.60%	67.00%	67.77%	71.56%	70.44%	65.04%	47.90%	55.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	29.69%	23.11%	23.12%	27.66%	31.32%	27.82%	29.18%	33.41%	35.54%	32.48%
Debt to EBITDA	3.25	3.49	4.76	3.79	3.94	4.42	4.56	3.94	3.97	5.19
Net Debt to EBITDA	3.03	3.44	4.66	3.67	3.58	3.86	3.80	3.26	3.22	4.16
Long-Term Debt to EBITDA	2.92	3.01	4.56	3.51	3.89	4.38	4.53	3.84	2.95	4.29
Debt to NOPAT	6.94	7.88	6.34	7.32	8.12	8.37	8.55	7.92	7.45	10.13
Net Debt to NOPAT	6.48	7.75	6.21	7.09	7.38	7.31	7.13	6.56	6.05	8.11
Long-Term Debt to NOPAT	6.24	6.78	6.07	6.78	8.01	8.29	8.50	7.73	5.54	8.37
Altman Z-Score	2.58	2.50	2.22	2.33	2.35	2.09	2.02	2.41	2.14	1.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.34	1.12	1.35	1.20	1.38	1.51	1.52	1.48	1.02	1.12
Quick Ratio	0.49	0.36	0.53	0.54	0.70	0.86	0.89	0.86	0.54	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	237	245	-852	461	325	-642	-186	599	345	-222
Operating Cash Flow to CapEx	142.03%	205.61%	223.45%	265.23%	219.69%	268.76%	242.67%	352.34%	214.43%	283.10%
Free Cash Flow to Firm to Interest Expense	3.54	3.61	-7.26	3.88	3.03	-6.10	-1.70	4.69	1.99	-1.33
Operating Cash Flow to Interest Expense	5.02	5.82	3.32	4.26	4.73	5.72	5.07	5.86	2.78	4.31
Operating Cash Flow Less CapEx to Interest Expense	1.48	2.99	1.84	2.66	2.57	3.59	2.98	4.19	1.49	2.79
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.16	1.14	1.05	0.96	0.94	0.86	0.80	0.85	0.80	0.72
Accounts Receivable Turnover	12.72	12.69	11.01	9.21	8.84	8.75	8.53	9.36	9.52	9.81
Inventory Turnover	5.45	5.04	5.22	5.54	5.96	6.19	6.45	6.84	5.84	5.18
Fixed Asset Turnover	3.44	3.17	3.09	2.96	0.00	0.00	0.00	3.27	3.08	2.76
Accounts Payable Turnover	7.12	6.32	5.93	5.48	5.25	5.30	4.92	5.09	4.87	4.43
Days Sales Outstanding (DSO)	28.69	28.75	33.15	39.63	41.31	41.70	42.78	38.98	38.32	37.21
Days Inventory Outstanding (DIO)	66.91	72.45	69.94	65.84	61.27	58.99	56.62	53.36	62.48	70.43
Days Payable Outstanding (DPO)	51.23	57.79	61.50	66.63	69.58	68.85	74.24	71.70	74.89	82.43
Cash Conversion Cycle (CCC)	44.38	43.42	41.59	38.84	33.00	31.84	25.16	20.63	25.91	25.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,053	2,006	3,260	3,113	3,064	4,095	4,724	4,558	4,673	5,304
Invested Capital Turnover	1.83	1.78	1.55	1.40	1.45	1.38	1.29	1.38	1.30	1.17
Increase / (Decrease) in Invested Capital	-19	-46	1,254	-147	-49	1,031	630	-166	115	630
Enterprise Value (EV)	2,853	2,926	5,443	4,643	5,265	6,739	7,716	8,372	7,530	8,873
Market Capitalization	1,440	1,389	2,950	2,411	3,224	3,897	4,555	5,532	4,746	5,559
Book Value per Share	$10.58	$7.78	$6.94	$7.97	$9.24	$11.33	$14.15	$15.61	$17.74	$18.63
Tangible Book Value per Share	($2.79)	($5.24)	($7.45)	($5.88)	($4.27)	($10.18)	($11.83)	($9.36)	($7.98)	($11.20)
Total Capital	2,153	2,031	3,313	3,186	3,268	4,504	5,356	5,144	5,316	6,126
Total Debt	1,514	1,562	2,547	2,305	2,244	3,251	3,793	3,425	3,427	4,137
Total Long-Term Debt	1,361	1,344	2,439	2,134	2,215	3,223	3,773	3,345	2,546	3,420
Net Debt	1,414	1,537	2,494	2,232	2,041	2,842	3,162	2,840	2,784	3,314
Capital Expenditures (CapEx)	236	192	174	191	231	224	229	212	225	255
Debt-free, Cash-free Net Working Capital (DFCFNWC)	316	293	389	308	214	226	176	189	275	169
Debt-free Net Working Capital (DFNWC)	416	317	442	381	418	636	808	775	917	992
Net Working Capital (NWC)	264	100	334	211	388	608	787	695	37	275
Net Nonoperating Expense (NNE)	46	45	132	91	83	80	85	92	134	132
Net Nonoperating Obligations (NNO)	1,414	1,537	2,494	2,232	2,041	2,842	3,162	2,840	2,784	3,314
Total Depreciation and Amortization (D&A)	146	147	178	196	210	224	256	268	269	281
Debt-free, Cash-free Net Working Capital to Revenue	8.41%	8.10%	9.51%	6.93%	4.77%	4.59%	3.10%	2.95%	4.58%	2.89%
Debt-free Net Working Capital to Revenue	11.06%	8.79%	10.82%	8.57%	9.31%	12.91%	14.23%	12.09%	15.32%	16.95%
Net Working Capital to Revenue	7.02%	2.78%	8.16%	4.74%	8.65%	12.34%	13.87%	10.84%	0.62%	4.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.83	$2.56	$2.44	$2.03	$1.75	$2.79	$3.25	$3.09	$3.00	$2.59
Adjusted Weighted Average Basic Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Adjusted Diluted Earnings per Share	$2.81	$2.55	$2.42	$2.01	$1.74	$2.77	$3.23	$3.07	$2.98	$2.58
Adjusted Weighted Average Diluted Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	60.39M	55.05M	110.39M	110.43M	110.78M	110.06M	110.41M	110.08M	106.50M	106.79M
Normalized Net Operating Profit after Tax (NOPAT)	228	193	231	291	306	371	416	453	470	455
Normalized NOPAT Margin	6.05%	5.34%	5.64%	6.55%	6.81%	7.55%	7.33%	7.07%	7.84%	7.77%
Pre Tax Income Margin	6.72%	6.42%	5.86%	6.59%	5.62%	8.27%	8.21%	7.40%	7.05%	5.94%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.78	4.42	3.04	3.47	3.35	4.87	5.25	4.71	3.44	3.08
NOPAT to Interest Expense	3.26	2.92	3.42	2.65	2.57	3.69	4.04	3.39	2.65	2.44
EBIT Less CapEx to Interest Expense	1.25	1.59	1.56	1.86	1.20	2.74	3.16	3.05	2.14	1.55
NOPAT Less CapEx to Interest Expense	-0.27	0.09	1.94	1.04	0.42	1.56	1.95	1.72	1.35	0.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.05%	26.66%	15.02%	19.89%	26.23%	17.38%	17.40%	21.11%	24.20%	29.69%
Augmented Payout Ratio	123.40%	209.72%	16.55%	23.38%	40.47%	31.02%	19.79%	34.35%	80.65%	33.06%

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.34%	1.12%	-1.64%	-7.58%	-8.49%	-7.92%	-7.14%	-3.18%	-3.22%	5.30%
EBITDA Growth	22.91%	-26.45%	-7.09%	-6.11%	-8.37%	36.58%	-9.07%	-1.53%	-9.73%	-10.86%
EBIT Growth	30.67%	-36.95%	-8.48%	-8.88%	-11.54%	55.43%	-14.87%	-1.49%	-13.81%	-25.28%
NOPAT Growth	29.38%	-60.96%	-7.45%	3.23%	-10.79%	126.65%	-15.71%	-8.10%	-8.73%	-11.57%
Net Income Growth	30.49%	-71.08%	-15.14%	-14.87%	-20.25%	161.96%	-23.41%	-3.54%	-9.55%	-30.06%
EPS Growth	30.21%	-69.74%	-14.47%	-14.46%	-18.40%	160.87%	-20.00%	0.00%	-8.82%	-30.00%
Operating Cash Flow Growth	15.17%	53.91%	-136.26%	-112.90%	-7.98%	24.56%	13.29%	111.61%	45.12%	-13.25%
Free Cash Flow Firm Growth	126.42%	140.24%	103.47%	69.50%	-233.55%	-108.58%	71.14%	259.23%	229.36%	-2,931.56%
Invested Capital Growth	-0.46%	-3.52%	1.34%	6.10%	7.52%	2.53%	0.67%	-4.09%	-3.37%	13.49%
Revenue Q/Q Growth	27.64%	-26.14%	-2.55%	0.60%	26.38%	-25.68%	-1.72%	4.88%	26.33%	-19.14%
EBITDA Q/Q Growth	26.04%	-50.09%	39.00%	7.36%	23.01%	-25.60%	-4.83%	16.27%	12.77%	-26.53%
EBIT Q/Q Growth	38.85%	-63.02%	61.72%	9.73%	34.79%	-35.02%	-11.42%	26.97%	17.93%	-43.67%
NOPAT Q/Q Growth	44.79%	-73.85%	133.41%	16.79%	25.12%	-33.55%	-13.20%	27.34%	24.26%	-35.62%
Net Income Q/Q Growth	49.67%	-82.27%	192.86%	9.53%	40.22%	-41.75%	-14.38%	37.95%	31.48%	-54.96%
EPS Q/Q Growth	50.60%	-81.60%	182.61%	9.23%	43.66%	-41.18%	-13.33%	36.54%	30.99%	-54.84%
Operating Cash Flow Q/Q Growth	377.30%	269.40%	-172.96%	71.51%	219.85%	400.05%	-150.79%	103.81%	1,397.94%	198.94%
Free Cash Flow Firm Q/Q Growth	126.53%	11.16%	-86.55%	-869.30%	-16.15%	92.86%	368.11%	615.74%	-5.64%	-267.42%
Invested Capital Q/Q Growth	-3.22%	-13.80%	19.25%	6.66%	-1.93%	-17.80%	17.08%	1.61%	-1.19%	-3.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.62%	15.99%	16.78%	17.53%	15.86%	16.31%	16.97%	18.53%	16.81%	16.94%
EBITDA Margin	14.44%	9.76%	13.92%	14.85%	14.46%	14.47%	13.63%	15.11%	13.49%	12.25%
Operating Margin	11.14%	5.58%	9.25%	10.09%	10.76%	9.41%	8.48%	10.27%	9.59%	6.68%
EBIT Margin	11.14%	5.58%	9.25%	10.09%	10.76%	9.41%	8.48%	10.27%	9.59%	6.68%
Profit (Net Income) Margin	7.04%	1.69%	5.08%	5.53%	6.13%	4.81%	4.19%	5.51%	5.73%	3.19%
Tax Burden Percent	74.71%	52.83%	76.25%	81.16%	75.34%	77.04%	75.49%	75.71%	79.78%	92.59%
Interest Burden Percent	84.62%	57.37%	71.98%	67.50%	75.65%	66.31%	65.41%	70.86%	74.97%	51.65%
Effective Tax Rate	25.29%	47.17%	23.75%	18.84%	24.66%	22.96%	24.51%	24.29%	20.22%	8.82%
Return on Invested Capital (ROIC)	10.04%	4.07%	8.35%	9.12%	9.02%	9.41%	6.91%	8.00%	7.91%	7.15%
ROIC Less NNEP Spread (ROIC-NNEP)	9.36%	3.46%	7.59%	8.14%	8.07%	8.24%	6.11%	7.17%	7.00%	5.81%
Return on Net Nonoperating Assets (RNNOA)	22.14%	6.33%	16.37%	18.09%	17.42%	12.85%	11.98%	14.23%	13.41%	9.13%
Return on Equity (ROE)	32.18%	10.40%	24.72%	27.21%	26.44%	22.26%	18.90%	22.23%	21.32%	16.27%
Cash Return on Invested Capital (CROIC)	9.79%	12.91%	6.52%	1.66%	0.21%	7.47%	7.48%	11.84%	10.99%	-4.45%
Operating Return on Assets (OROA)	9.45%	4.73%	7.59%	8.02%	8.57%	7.54%	6.47%	7.69%	7.13%	4.83%
Return on Assets (ROA)	5.98%	1.43%	4.17%	4.39%	4.88%	3.85%	3.19%	4.12%	4.26%	2.31%
Return on Common Equity (ROCE)	32.18%	10.40%	24.72%	27.21%	26.44%	22.26%	18.90%	22.23%	21.32%	16.27%
Return on Equity Simple (ROE_SIMPLE)	23.70%	0.00%	18.41%	16.79%	16.06%	0.00%	16.27%	15.84%	14.40%	0.00%
Net Operating Profit after Tax (NOPAT)	164	43	100	117	146	97	84	107	133	86
NOPAT Margin	8.32%	2.95%	7.06%	8.19%	8.11%	7.25%	6.40%	7.77%	7.65%	6.09%
Net Nonoperating Expense Percent (NNEP)	0.68%	0.61%	0.76%	0.98%	0.95%	1.16%	0.81%	0.83%	0.91%	1.34%
Return On Investment Capital (ROIC_SIMPLE)	-	0.83%	-	-	-	1.83%	-	-	-	1.40%
Cost of Revenue to Revenue	84.38%	84.01%	83.22%	82.47%	84.14%	83.69%	83.03%	81.47%	83.19%	83.06%
SG&A Expenses to Revenue	4.91%	6.63%	7.14%	7.16%	4.68%	7.21%	7.63%	7.80%	6.10%	8.77%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.48%	10.41%	7.53%	7.44%	5.09%	6.90%	8.49%	8.26%	7.22%	10.26%
Earnings before Interest and Taxes (EBIT)	219	81	131	144	194	126	112	142	167	94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	285	142	197	212	261	194	179	209	235	173
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.66	3.22	3.25	2.72	2.62	2.51	2.71	2.34	2.73	2.79
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.71	0.86	0.91	0.81	0.76	0.79	0.88	0.77	0.97	0.95
Price to Earnings (P/E)	11.24	16.23	17.65	16.18	16.30	14.56	16.66	14.76	18.96	20.11
Dividend Yield	1.52%	1.27%	1.26%	1.47%	1.65%	1.62%	1.51%	1.75%	1.43%	1.46%
Earnings Yield	8.90%	6.16%	5.67%	6.18%	6.14%	6.87%	6.00%	6.78%	5.28%	4.97%
Enterprise Value to Invested Capital (EV/IC)	1.53	1.84	1.74	1.55	1.51	1.61	1.59	1.47	1.65	1.67
Enterprise Value to Revenue (EV/Rev)	1.27	1.31	1.48	1.44	1.40	1.26	1.48	1.39	1.56	1.52
Enterprise Value to EBITDA (EV/EBITDA)	8.85	9.62	11.13	10.81	10.60	8.71	10.31	9.66	11.06	11.14
Enterprise Value to EBIT (EV/EBIT)	12.48	13.91	16.01	15.65	15.56	12.65	15.15	14.20	16.54	17.23
Enterprise Value to NOPAT (EV/NOPAT)	16.39	19.35	22.26	21.11	20.94	16.38	19.64	18.73	21.40	21.72
Enterprise Value to Operating Cash Flow (EV/OCF)	18.21	11.19	24.59	31.22	31.74	15.60	15.40	10.61	10.46	12.29
Enterprise Value to Free Cash Flow (EV/FCFF)	15.62	13.97	26.80	96.37	748.89	21.85	21.38	12.12	14.72	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.27	1.99	2.33	2.22	2.36	1.81	2.04	2.03	1.85	2.08
Long-Term Debt to Equity	1.92	1.95	1.89	1.79	1.86	1.35	1.33	1.31	1.24	1.72
Financial Leverage	2.37	1.83	2.16	2.22	2.16	1.56	1.96	1.98	1.91	1.57
Leverage Ratio	4.78	4.61	4.55	4.52	4.41	4.15	4.19	4.10	4.06	4.18
Compound Leverage Factor	4.05	2.64	3.28	3.05	3.34	2.75	2.74	2.91	3.04	2.16
Debt to Total Capital	69.39%	66.59%	69.99%	68.99%	70.26%	64.46%	67.13%	67.02%	64.96%	67.52%
Short-Term Debt to Total Capital	10.69%	1.56%	13.22%	13.45%	14.98%	16.56%	23.28%	23.85%	21.40%	11.70%
Long-Term Debt to Total Capital	58.70%	65.04%	56.77%	55.54%	55.28%	47.90%	43.85%	43.17%	43.56%	55.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	30.61%	33.41%	30.01%	31.01%	29.74%	35.54%	32.87%	32.98%	35.04%	32.48%
Debt to EBITDA	4.19	3.94	4.90	5.00	5.21	3.97	4.59	4.66	4.66	5.19
Net Debt to EBITDA	3.92	3.26	4.31	4.71	4.83	3.22	4.22	4.30	4.21	4.16
Long-Term Debt to EBITDA	3.55	3.84	3.97	4.02	4.10	2.95	3.00	3.00	3.12	4.29
Debt to NOPAT	7.76	7.92	9.80	9.75	10.29	7.45	8.73	9.03	9.01	10.13
Net Debt to NOPAT	7.27	6.56	8.61	9.20	9.54	6.05	8.04	8.34	8.14	8.11
Long-Term Debt to NOPAT	6.57	7.73	7.95	7.85	8.10	5.54	5.71	5.82	6.04	8.37
Altman Z-Score	2.07	2.18	2.09	2.02	2.01	1.94	1.98	1.91	2.05	1.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.39	1.48	1.42	1.44	1.39	1.02	1.04	1.06	1.09	1.12
Quick Ratio	0.81	0.86	0.78	0.69	0.84	0.54	0.55	0.57	0.68	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	188	209	28	-216	-251	-18	48	345	325	-544
Operating Cash Flow to CapEx	533.80%	1,618.87%	-935.98%	-359.73%	397.28%	2,026.37%	-752.87%	37.52%	518.63%	1,414.07%
Free Cash Flow to Firm to Interest Expense	5.58	6.05	0.77	-4.63	-5.32	-0.42	1.25	8.34	7.77	-11.95
Operating Cash Flow to Interest Expense	6.95	25.03	-17.18	-3.85	4.56	25.38	-14.17	0.51	7.48	20.54
Operating Cash Flow Less CapEx to Interest Expense	5.65	23.49	-19.02	-4.92	3.42	24.13	-16.06	-0.84	6.03	19.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.85	0.82	0.79	0.80	0.80	0.76	0.75	0.74	0.72
Accounts Receivable Turnover	5.93	9.36	7.14	6.27	5.04	9.52	6.26	5.50	4.62	9.81
Inventory Turnover	6.65	6.84	5.15	4.18	5.76	5.84	4.88	4.30	5.64	5.18
Fixed Asset Turnover	3.32	3.27	3.27	3.24	3.21	3.08	3.04	3.02	2.99	2.76
Accounts Payable Turnover	7.41	5.09	6.81	6.42	7.61	4.87	7.40	6.89	7.20	4.43
Days Sales Outstanding (DSO)	61.57	38.98	51.11	58.17	72.36	38.32	58.35	66.37	79.08	37.21
Days Inventory Outstanding (DIO)	54.86	53.36	70.93	87.22	63.38	62.48	74.81	84.80	64.72	70.43
Days Payable Outstanding (DPO)	49.29	71.70	53.60	56.84	47.99	74.89	49.31	52.97	50.67	82.43
Cash Conversion Cycle (CCC)	67.15	20.63	68.44	88.56	87.74	25.91	83.85	98.20	93.13	25.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,288	4,558	5,435	5,797	5,685	4,673	5,472	5,560	5,494	5,304
Invested Capital Turnover	1.21	1.38	1.18	1.11	1.11	1.30	1.08	1.03	1.03	1.17
Increase / (Decrease) in Invested Capital	-24	-166	72	333	398	115	36	-237	-192	630
Enterprise Value (EV)	8,104	8,372	9,442	9,011	8,567	7,530	8,723	8,146	9,045	8,873
Market Capitalization	4,509	5,532	5,788	5,085	4,663	4,746	5,151	4,520	5,606	5,559
Book Value per Share	$15.36	$15.61	$16.18	$16.97	$16.21	$17.74	$17.84	$18.11	$19.24	$18.63
Tangible Book Value per Share	($8.89)	($9.36)	($8.87)	($8.00)	($8.39)	($7.98)	($7.51)	($6.92)	($6.10)	($11.20)
Total Capital	5,531	5,144	5,936	6,034	5,992	5,316	5,780	5,863	5,862	6,126
Total Debt	3,838	3,425	4,155	4,163	4,210	3,427	3,880	3,929	3,808	4,137
Total Long-Term Debt	3,247	3,345	3,370	3,351	3,313	2,546	2,535	2,531	2,554	3,420
Net Debt	3,594	2,840	3,654	3,926	3,903	2,784	3,572	3,626	3,440	3,314
Capital Expenditures (CapEx)	44	53	67	50	54	53	73	56	60	66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	998	189	1,065	1,394	1,337	275	1,124	1,238	1,100	169
Debt-free Net Working Capital (DFNWC)	1,242	775	1,566	1,630	1,644	917	1,433	1,541	1,468	992
Net Working Capital (NWC)	651	695	781	819	746	37	87	143	214	275
Net Nonoperating Expense (NNE)	25	18	28	38	36	33	29	31	33	41
Net Nonoperating Obligations (NNO)	3,594	2,840	3,654	3,926	3,903	2,784	3,572	3,626	3,440	3,314
Total Depreciation and Amortization (D&A)	65	61	66	68	67	68	68	67	68	79
Debt-free, Cash-free Net Working Capital to Revenue	15.61%	2.95%	16.67%	22.22%	21.90%	4.58%	19.09%	21.19%	19.01%	2.89%
Debt-free Net Working Capital to Revenue	19.42%	12.09%	24.51%	26.00%	26.94%	15.32%	24.34%	26.38%	25.38%	16.95%
Net Working Capital to Revenue	10.18%	10.84%	12.22%	13.06%	12.23%	0.62%	1.48%	2.44%	3.70%	4.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.26	$0.22	$0.65	$0.72	$1.02	$0.61	$0.52	$0.71	$0.94	$0.42
Adjusted Weighted Average Basic Shares Outstanding	110.28M	110.08M	110.22M	110.13M	108.42M	106.50M	106.65M	106.84M	106.85M	106.79M
Adjusted Diluted Earnings per Share	$1.25	$0.23	$0.65	$0.71	$1.02	$0.60	$0.52	$0.71	$0.93	$0.42
Adjusted Weighted Average Diluted Shares Outstanding	110.74M	110.08M	110.85M	110.45M	108.75M	106.50M	107.05M	107.02M	107.14M	106.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	110.08M	110.08M	110.25M	109.95M	106.50M	106.50M	106.78M	106.78M	106.79M	106.79M
Normalized Net Operating Profit after Tax (NOPAT)	158	72	104	120	152	94	93	112	149	105
Normalized NOPAT Margin	8.00%	4.94%	7.35%	8.42%	8.42%	7.01%	7.05%	8.13%	8.54%	7.44%
Pre Tax Income Margin	9.42%	3.20%	6.66%	6.81%	8.14%	6.24%	5.55%	7.28%	7.19%	3.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.50	2.35	3.57	3.08	4.11	2.97	2.89	3.43	4.00	2.07
NOPAT to Interest Expense	4.86	1.24	2.72	2.50	3.09	2.29	2.18	2.60	3.19	1.89
EBIT Less CapEx to Interest Expense	5.20	0.80	1.73	2.01	2.96	1.72	1.01	2.08	2.55	0.62
NOPAT Less CapEx to Interest Expense	3.56	-0.31	0.89	1.43	1.95	1.03	0.30	1.25	1.75	0.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.39%	21.11%	22.50%	24.09%	27.03%	24.20%	25.71%	26.09%	27.37%	29.69%
Augmented Payout Ratio	27.21%	34.35%	36.85%	35.77%	93.31%	80.65%	83.38%	78.57%	30.00%	33.06%

Frequently Asked Questions About Silgan's Financials

When does Silgan's financial year end?

According to the most recent income statement we have on file, Silgan's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Silgan's net income changed over the last 9 years?

Silgan's net income appears to be on an upward trend, with a most recent value of $276.38 million in 2024, rising from $172.41 million in 2015. The previous period was $325.97 million in 2023.

What is Silgan's operating income?

Silgan's total operating income in 2024 was $515.10 million, based on the following breakdown:

Total Gross Profit: $1.01 billion
Total Operating Expenses: $496.68 million

How has Silgan revenue changed over the last 9 years?

Over the last 9 years, Silgan's total revenue changed from $3.76 billion in 2015 to $5.85 billion in 2024, a change of 55.5%.

How much debt does Silgan have?

Silgan's total liabilities were at $6.60 billion at the end of 2024, a 15.3% increase from 2023, and a 158.3% increase since 2015.

How much cash does Silgan have?

In the past 9 years, Silgan's cash and equivalents has ranged from $24.69 million in 2016 to $822.85 million in 2024, and is currently $822.85 million as of their latest financial filing in 2024.

How has Silgan's book value per share changed over the last 9 years?

Over the last 9 years, Silgan's book value per share changed from 10.58 in 2015 to 18.63 in 2024, a change of 76.0%.

Remove Ads

Related Companies

This page (NYSE:SLGN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silgan (SLGN) Financials

Frequently Asked Questions About Silgan's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silgan (SLGN) Financials

Annual Income Statements for Silgan

Quarterly Income Statements for Silgan

Annual Cash Flow Statements for Silgan

Quarterly Cash Flow Statements for Silgan

Annual Balance Sheets for Silgan

Quarterly Balance Sheets for Silgan

Annual Metrics and Ratios for Silgan

Quarterly Metrics and Ratios for Silgan

Frequently Asked Questions About Silgan's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools